vitx وراه ارتداد والله اعلم .

battal

عضو نشط
التسجيل
31 مايو 2004
المشاركات
154
يعني أجلس أتابع السوق؟؟

لأن عندي دوام الساعة 10.30

ما رأيك أضع أمر بيع ام أتركها وأرى ماسيحدث غدا؟؟

=============================
اذا ..... اذهب واترك السهم ولاتبيع ولا تضع أمر لابيع ولاشراء الا السبوع القادم ,, وأعتقد أنك سوف ترى العجب ....بحول الله وقوته ومشيئته .
 

$$ الطمـــوح $$

عضو نشط
التسجيل
12 أغسطس 2004
المشاركات
476
battal قال:
يعني أجلس أتابع السوق؟؟

لأن عندي دوام الساعة 10.30

ما رأيك أضع أمر بيع ام أتركها وأرى ماسيحدث غدا؟؟

=============================
اذا ..... اذهب واترك السهم ولاتبيع ولا تضع أمر لابيع ولاشراء الا السبوع القادم ,, وأعتقد أنك سوف ترى العجب ....بحول الله وقوته ومشيئته .


الله يعطيك العافيه

وسوف آخذ بنصيحتك

والله يكتب اللي فيه خير للجميع

ولكن ممكن سؤال للإطمئنان:

على أي أساس بنيت كلامك؟؟

هل هو من متابعتك للشركة أم ماذا؟؟

وكم تتوقعى لها؟؟

علما إني دخلت على توصيتك لأني لم استطع احللها فنيا :D

والله يجزاك خير
 

battal

عضو نشط
التسجيل
31 مايو 2004
المشاركات
154
كم لك باسواق الاسهم اخي الطموح عامة الخليجية والعربية والعالمية ... أجبني لو تكرمت على الخاص...
 

abooyaser

عضو محترف - مشرف القسم السعودي
التسجيل
24 مايو 2004
المشاركات
3,425
الوعد

20 يناير

وبس

ولو نزل
لن يغادر المحفظه الا
بتأشيرة بعد طلب من ....
 

battal

عضو نشط
التسجيل
31 مايو 2004
المشاركات
154
انا الان اقر واعترف واوقع على بياض ان السعر المستهدف مبدئيا 3 دولار انشاءالله
 

maseela77

عضو نشط
التسجيل
27 نوفمبر 2004
المشاركات
344
الإقامة
الكويت
ما سبب ذلك اخي بتال ؟
 

msn

موقوف
التسجيل
19 يونيو 2004
المشاركات
66
battal قال:
انا الان اقر واعترف واوقع على بياض ان السعر المستهدف مبدئيا 3 دولار انشاءالله
Stock Rating > V I Technologies Inc (NASDAQ:VITX) > SELL
StockPickReport.Com research suggests VITX's price will move lower than the "open price" the day this rating was initiated. This analysis is based on short-term stochastic and "relative strength" indicators. With StockPickReport.Com's "Sell" rating, stochastic and "relative strength" numbers may agree, but not in all cases. Investors, traders, and other market participants may find this a good opportunity to sell VITX, "sell calls", or "buy puts". This may also be an opportunity to lower targets and raise stop/losses to protect capital. Trading volume seems to be going up and VITX's closing price moved up during the week before this rating was initiated.
About VITX: [read less]
V.I. Technologies, Inc. develops biotechnology products designed to improve the safety of the world?s blood supply. It proprietary INACTINE? Pathogen Reduction System for red cells is designed to inactivate a wide range of viruses, bacteria, parasites, and lymphocytes from red blood cells, while maintaining the therapeutic properties of the red blood cells. The INACTINE system also demonstrated in non-clinical trials, efficiency in removing prion proteins. Prion proteins in their pathogenic forms are the agents that cause ?Mad Cow Disease?, or in humans, variant Creutzfeldt-Jakob Disease. The company?s technology works by binding to the RNA or DNA of the pathogen. Once bound, the compound forms an irreversible bond to the nucleic acid, preventing replication and thereby killing the pathogens. As of March 31, 2003, INACTINE was in Phase III clinical trials. As of that date, the company did not have any approved products; and had not made any commercial sales of its products under development. V.I. has partnerships with Pall Corporation, Haemonetics Corporation, and Amersham Pharmacia Biotech. Competitors of the company include Cerus Corporation and Gambro.

هذا تحذير ان السعر بينزل ؟؟؟؟؟؟؟؟؟
 

Day_trading

موقوف
التسجيل
28 أغسطس 2004
المشاركات
1,931
الإقامة
kuwait
Market Pulse Breaking News Alert for Thursday, January 13, 2005: LFTC - Lifestream's CEO to Testify at FDA Hearing Considering Over-the-Counter Petition for Cholesterol Lowering Drugs!


Market Wire - Thursday, January 13, 2005

--------------------------------------------------------------------------------

ATLANTA, GA -- (MARKET WIRE) -- 13-01-2005 -- Market Pulse News Alert for this AM, Stocks to Watch are: Lifestream Technologies, Inc. (OTC BB: LFTC), Myriad Genetics Inc. (NASDAQ: MYGN), V.I. Technologies, Inc. (NASDAQ: VITX), and eBay Inc. (NASDAQ: EBAY).
Investors need to be watching Lifestream Technologies, Inc. (OTC BB: LFTC) this AM! Lifestream develops, markets and sells a line of smart card-enabled healthcare diagnostic devices. Lifestream has developed and currently markets a line of cholesterol monitors that provide test results in three minutes for at-home use by health conscious consumers and at-risk medical patients. Lifestream just had excellent news out before today's opening bell regarding their CEO being scheduled to testify at the FDA hearing considering an over-the-counter petition for cholesterol lowering drugs! This could be great news for investors!

Lifestream Technologies, Inc. (OTC BB: LFTC), a leading supplier of cholesterol monitors, is scheduled to testify at the FDA hearing considering an over-the-counter petition for cholesterol lowering drugs. Christopher Maus will address the Nonprescription Drugs Advisory Committee (NDAC) and the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) during the public comment period on Friday morning, January 14.

"Lifestream's home cholesterol monitor can have a material impact in the FDA's consideration of this petition," said Maus. "I look forward to this opportunity to address any testing concerns the FDA may have, as the benefit of home testing on an individual's effort to take control by personal health management is acknowledged. With Lifestream's affordable, easy and accurate suite of testing products, it is well positioned to support the public's desire to take control of their cholesterol levels. We support government and industry efforts to give more control of preventive health care decisions to individuals."

"Lifestream's new cholesterol monitor with Health Risk Assessment takes testing one step further by giving an individual the ability to understand combined risk factors and the effects those factors may have on their heart health as defined in the NCEP ATP III guidelines," Maus stated. "Recently cleared by the FDA, Lifestream's cholesterol monitor with HRA supports efforts to expand cholesterol management programs. The NCEP ATP III recommends home testing as an important tool for individuals as part of their professional healthcare program. Regardless of an individual's choice of lifestyle changes or the use of prescriptive or non-prescriptive therapies, monitoring cholesterol is a key factor for meaningful outcomes."

About Lifestream Technologies

The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.

In addition to the professional monitor, the Company's product line aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.

Lifestream's monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern™ Personal Health Card® allowing multiple users the ability to store their personal results. Lifestream's products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream's products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.

Stocks acting well as of late include: Myriad Genetics Inc. (NASDAQ: MYGN), V.I. Technologies, Inc. (NASDAQ: VITX), and eBay Inc. (NASDAQ: EBAY).

Information contained herein is the opinion of Market-Pulse.com ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP's analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.

MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company.

You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP's statements regarding a company. MP has been compensated in free trading shares of common stock, available for public trading as follows: Lifestream Technologies, Inc. compensation from a third party: three million free trading shares of stock in Lifestream Technologies, Inc., already delivered from a third party. An additional three million restricted shares are pending from Lifestream Technologies, Inc. To date, MP has sold three million shares of stock in Lifestream Technologies, Inc. for proceeds totaling ninety five thousand dollars. MP's officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. Market Pulse News Alert is a division of MP.
??????????
هل من تفسير
 

battal

عضو نشط
التسجيل
31 مايو 2004
المشاركات
154
اللي يبي الثروة لايغادر محفظته هذا السهم ... وبس ,,,, اقسم بالله اني لا املك الان فيه ولا سهم
لأني أعشق المضاربة .... ولا اصبر عنها ....
 

abooyaser

عضو محترف - مشرف القسم السعودي
التسجيل
24 مايو 2004
المشاركات
3,425
لهذا السبب

وافق الfda على المرحله الثانيه من دواء علاج الايدز وبسرعه وستدخل المرحله

الثالثه والاخيره للدواء السهم لايوجد له اي تصور او حدود

10$ او 15$ او اكثر

نقلا عن منتدى اعمال الخليج .....

السؤال : كم عدد مرضي الإيدز .... والعياذ بالله ...
الجواب : بالملايين ...وكل واحد يتمنى الشفاء من غلطته ... ويتوب

السؤال : لو نجح الدواء واعتمد وبدأت عمليات انتاجه وبيعه حتي لو بغالي
الجواب: اول من يشتريه الاغنياء المصابين او لأقربائهم المصابين
وغير هم من المؤساسات الخيريه والطبيه ...

هل تتوقع سعر السهم بيبقي بالوضع الحالي ....
السهم في نظري شيك مصدق ...للزمن القادم ...اقل وقت انتظار سنه
وبعدها لها الف حلالالال ....

تحياتي الحاره .... :) :) :)
 

alrabeet

عضو نشط
التسجيل
17 مارس 2003
المشاركات
1,163
اخواني في الله

العلاج لن ينجح لن ينجح لن ينجح

تدرون ليش : لان علاج الايدز معروف وهو ((((((((( الوقايه من ارتكاب الزنا والمحرمات الاخرى )))))))

فلا احد يحلم

وسجلوها علي اذا نجح
لان الايدز عقاب من الله
وكل داء انزل الله له دواء . ودواءه كما ذكرت

لااقول 10 او 100 دولار مستحيل لانه اذا وصل الى هذه المستويات سيكون قبل الاعلان

هذا والله اعلم
 

وليدخالد

عضو نشط
التسجيل
11 فبراير 2004
المشاركات
233
السلام ممكن العلاج ينجح والله ما انزل داء الا له دواء وقبل 50 سنه كان السيلان مثل الأيدز والأن يعتبر مثل الزكام لاكن انا من وجهت نظري صعب انهم ينجحون في الدواء لأن طريقه العلاج معقده وفيها خطوره
 

$$ الطمـــوح $$

عضو نشط
التسجيل
12 أغسطس 2004
المشاركات
476
أخوي alrabeet

مع إحترامي لوجهة نظرك لكن أعتقد إنه ممكن إيجاد دواء لهذا المرض

وكما ذكرت كل داء أنزل الله له دواء

ممكن يخترعون دواء وينجح ولكن هل هو نهاية المطاف!!!

بالتأكيد لا وسوف ينزل الله مرض آخر كما نشهد الأيام هذه كل يوم نكتشف مرض جديد وغريب ولا ننسى ((جنون البقر )) :D

وإذا كان كلامك صحيح فلن نشاهد دواء للسكر لأن علاجه الوقاية :confused:

الصراحة انا قلت هالكلام كوجهة نظر وكي أطمأن نفسي :D

وإختلاف وجهات النظر لا يفسد للود قضية :)
 

alrabeet

عضو نشط
التسجيل
17 مارس 2003
المشاركات
1,163
وإختلاف وجهات النظر لا يفسد للود قضية

والسكر غير الايدز ;)

وصحيح .....وما يعلم جنود ربك الا هو ......
يمكن يروح العقاب هذا وياتي ثاني

اتمنى لكم التوفيق :)
 

circle

موقوف
التسجيل
5 نوفمبر 2004
المشاركات
4,611
الإقامة
الكويت
يا جماعه امركم عجيب فى هذا المنتدى المفروض يتم نقاش الراى المطروح ... هل السهم مقبل على الارتفاع او لا .....
الكل يعرف الايدز وغيره من الامراض واسبابها .. التركيز على السهم افضل .
والله الهادى :confused:
 

$$ الطمـــوح $$

عضو نشط
التسجيل
12 أغسطس 2004
المشاركات
476
أخوي circle

الله يعطيك العافية

الأيدز والسهم مرتبطان ببعض

فالشركة مقبلة على إختراع دواء لهذا المريض الخبيث نسأل الله ان يكفينا شره وجميع المسلمين

وكنا نتناقش هل سينجح وتتطير الشركة ام سيسقط ولا يوافق عليه فتسقط الشركة معه

وسلامتك :)

وهدي أعصابك :D

شكلك شاري فيه كمية كبيرة وحاس إنك متورط :D

بالتوفيق لك ولجميع الأخوان
 

آلة الزمن

عضو نشط
التسجيل
12 يناير 2005
المشاركات
25
alrabeet

أخي العزيز .. لا يوجد دليل أن هذا عقاب من الله .. واسمح لي .. ماذنب الذين ينقل لهم دم ملوث ؟؟ لقد حدث هذا كثيرا .. ومازال يحدث .. ماذنب الذي يحلقون لهم ذقونهم في الصالونات باستخدام أمواس حلاقة أكثر من مرة .. دون أن يعلم الزبون بذلك .. ليس كل من يصابون بالإيدز زناة وشواذ

ليس كل كارثة تحل بنا عقاب عقاب يا أخي الكريم :)
 

abooyaser

عضو محترف - مشرف القسم السعودي
التسجيل
24 مايو 2004
المشاركات
3,425
مرض الايدز عقاب دون ادني شك

والرحمة من الله موجوده
المهم التقييم المستمر
مع وضع هدف سعري للسهم
لمن يحب ان يقطف ....بالنسبه لي وهذا الشيء شخصي

السهم لن يغادر المحفظه الا بتأشيره ....ليه...!!!!
العلاج في المرحلة الثانيه كما ذكر سابقا ...
والمرحلة الثالثه لها ثمارها ...
سلالالالالالالالالالالالالالالالام
 

Day_trading

موقوف
التسجيل
28 أغسطس 2004
المشاركات
1,931
الإقامة
kuwait
Day_trading قال:
Market Pulse Breaking News Alert for Thursday, January 13, 2005: LFTC - Lifestream's CEO to Testify at FDA Hearing Considering Over-the-Counter Petition for Cholesterol Lowering Drugs!


Market Wire - Thursday, January 13, 2005

--------------------------------------------------------------------------------

ATLANTA, GA -- (MARKET WIRE) -- 13-01-2005 -- Market Pulse News Alert for this AM, Stocks to Watch are: Lifestream Technologies, Inc. (OTC BB: LFTC), Myriad Genetics Inc. (NASDAQ: MYGN), V.I. Technologies, Inc. (NASDAQ: VITX), and eBay Inc. (NASDAQ: EBAY).
Investors need to be watching Lifestream Technologies, Inc. (OTC BB: LFTC) this AM! Lifestream develops, markets and sells a line of smart card-enabled healthcare diagnostic devices. Lifestream has developed and currently markets a line of cholesterol monitors that provide test results in three minutes for at-home use by health conscious consumers and at-risk medical patients. Lifestream just had excellent news out before today's opening bell regarding their CEO being scheduled to testify at the FDA hearing considering an over-the-counter petition for cholesterol lowering drugs! This could be great news for investors!

Lifestream Technologies, Inc. (OTC BB: LFTC), a leading supplier of cholesterol monitors, is scheduled to testify at the FDA hearing considering an over-the-counter petition for cholesterol lowering drugs. Christopher Maus will address the Nonprescription Drugs Advisory Committee (NDAC) and the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) during the public comment period on Friday morning, January 14.

"Lifestream's home cholesterol monitor can have a material impact in the FDA's consideration of this petition," said Maus. "I look forward to this opportunity to address any testing concerns the FDA may have, as the benefit of home testing on an individual's effort to take control by personal health management is acknowledged. With Lifestream's affordable, easy and accurate suite of testing products, it is well positioned to support the public's desire to take control of their cholesterol levels. We support government and industry efforts to give more control of preventive health care decisions to individuals."

"Lifestream's new cholesterol monitor with Health Risk Assessment takes testing one step further by giving an individual the ability to understand combined risk factors and the effects those factors may have on their heart health as defined in the NCEP ATP III guidelines," Maus stated. "Recently cleared by the FDA, Lifestream's cholesterol monitor with HRA supports efforts to expand cholesterol management programs. The NCEP ATP III recommends home testing as an important tool for individuals as part of their professional healthcare program. Regardless of an individual's choice of lifestyle changes or the use of prescriptive or non-prescriptive therapies, monitoring cholesterol is a key factor for meaningful outcomes."

About Lifestream Technologies

The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.

In addition to the professional monitor, the Company's product line aids the health conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.

Lifestream's monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern™ Personal Health Card® allowing multiple users the ability to store their personal results. Lifestream's products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream's products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.

Stocks acting well as of late include: Myriad Genetics Inc. (NASDAQ: MYGN), V.I. Technologies, Inc. (NASDAQ: VITX), and eBay Inc. (NASDAQ: EBAY).

Information contained herein is the opinion of Market-Pulse.com ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP's analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.

MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company.

You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP's statements regarding a company. MP has been compensated in free trading shares of common stock, available for public trading as follows: Lifestream Technologies, Inc. compensation from a third party: three million free trading shares of stock in Lifestream Technologies, Inc., already delivered from a third party. An additional three million restricted shares are pending from Lifestream Technologies, Inc. To date, MP has sold three million shares of stock in Lifestream Technologies, Inc. for proceeds totaling ninety five thousand dollars. MP's officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services. Market Pulse News Alert is a division of MP.
??????????
هل من تفسير
اموت اعرف شنو معناة الخبر هذا
 

alrabeet

عضو نشط
التسجيل
17 مارس 2003
المشاركات
1,163
آلة الزمن

اذا انت زعلان من كلامي وخايف انه يؤثر على السهم
فاقولك السهم مايدري عن كلامي
وبعدين وش الفرق بين الكارثه والعقوبه ؟
ولا تنسى ان هناك اشياء اسمها ( ابتلاء من الله )

وارجوا ان تكتب ردك في استراحة المنتدى حتى ما نزعج اهل السهم ويطردونا :)
 
أعلى